Kevin ten Haaf

Erasmus MC — Netherlands

Medicine · Health Sciences

34h-index7.9kcitations98works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(79), Lung Cancer Treatments and Mutations(50), Global Cancer Incidence and Screening(44), Radiomics and Machine Learning in Medical Imaging(29), Colorectal Cancer Screening and Detection(13)

Publications97 total

Eligibility and Prognostic Performance of Smoking Duration–Based Versus Pack-Year–Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic Groups
Annals of Internal Medicine·2025· 1 cited
Impact of lung cancer screening eligibility criteria on participants' characteristics and healthcare resources
International Journal of Cancer·2025Open Access
Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling study
EClinicalMedicine·2025Open Access
A comparative analysis of heterogeneity in lung cancer screening effectiveness in two randomised controlled trials
Nature Communications·2025Open Access
Impact of recruitment method on informed decision-making in lung cancer screening in the 4-IN-THE-LUNG-RUN trial
Lung Cancer·2025· 2 citedOpen Access
Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer
JAMA Network Open·2025· 2 citedOpen Access
Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the <scp>NELSON</scp> screening protocol—A modeling study
International Journal of Cancer·2025· 1 citedOpen Access
Towards dynamic risk assessments in lung cancer screening
Thorax·2025Open Access
Paradigm shift in early detection: Lung cancer screening to comprehensive CT screening
European Journal of Cancer·2025· 12 citedOpen Access
Impact of Recruitment Method on Informed Decision-Making in Lung Cancer Screening in the 4-IN-THE-LUNG-RUN trial
SSRN Electronic Journal·2025Open Access
Targeted lung cancer screening in the age of immunotherapies and targeted therapies – an economic evaluation for Australia
The Lancet Regional Health - Western Pacific·2024· 5 citedOpen Access
P4.04D.08 Natural History Model for Second Primary Lung Cancer Among Lung Cancer Survivors: Utilizing the U.S. SEER Cancer Registries
Journal of Thoracic Oncology·2024Open Access
OA17.06 Impact of Using Smoking Duration in Place of Pack-Years as Eligibility Criteria for Lung Cancer Screening to Reduce Racial and Ethnic Disparities
Journal of Thoracic Oncology·2024
P4.04D.04 Efficiency of the Annual CT Screening Interval for Those at a Lower Risk of Lung Cancer - A CISNET Comparative Modelling Study
Journal of Thoracic Oncology·2024· 1 citedOpen Access
Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021)
European Journal of Cancer·2024· 15 citedOpen Access
The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations
Medical Decision Making·2024· 6 citedOpen Access
Projected effectiveness of lung cancer screening and concurrent smoking cessation support in the Netherlands
EClinicalMedicine·2024· 10 citedOpen Access
Considerations for Enhancing Lung Cancer Risk Prediction and Screening in Asian Populations
Journal of Thoracic Oncology·2024Open Access
Assessing the impact of increasing lung screening eligibility by relaxing the maximum years‐since‐quit threshold: A simulation modeling study
Cancer·2023· 18 citedOpen Access
P1.14-04 European Lung Cancer Screening Implementation: 4-IN-THE-LUNG-RUN trial
Journal of Thoracic Oncology·2023· 11 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Harry J. de Koning(42), Rafael Meza(16), Jihyoun Jeon(14), Summer S. Han(14), Sylvia K. Plevritis(12), Chung Yin Kong(12), Martin C. Tammemägi(12), Carlijn M. van der Aalst(11), Matthijs Oudkerk(11), Eric J. Feuer(11), Erik F. Blom(9), Iakovos Toumazis(8), Pianpian Cao(8), Marjolein A. Heuvelmans(7), Uraujh Yousaf-Khan(7), Rozemarijn Vliegenthart(7), Mehrad Bastani(7), Carlijn van der Aalst(7), Pim A. de Jong(6), Kristiaan Nackaerts(6)